BioNote, Inc. (KOSE: A377740)
Health Care · Biotechnology · KR
₩4,640.00
-1.28% today · -20.5% 1Y
BioNote, Inc. (KOSE: A377740) operates in the Biotechnology industry within the Health Care sector. The company is valued at $348.29M.
Over the last twelve months the share price has lost 20.5%, trading between 4.05K and 6.26K.
Tweenvest scores BioNote, Inc. across four factors: quality 82/100, value 56/100, dividend 100/100. Its strongest factor is dividend.
A377740 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $348.29M
- Revenue (TTM)
- $81.63M
- P/E
- —
- EPS
- -1,246.93
- Dividend yield
- 4.91%
- Beta (5Y)
- 0.63
- 52-week high
- ₩6,260.00
- 52-week low
- ₩4,050.00
- Avg volume (3M)
- —
- Shares outstanding
- 100.91M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Jiangsu CoWin Biotech Co., Ltd.SHSE: 688426 | $353.03M | CN¥21.51 | -4.74% |
| Jiangsu Gdk Biological Technology Co., LtdSHSE: 688670 | $352.60M | CN¥19.17 | +2.35% |
| BioDlink International Company LimitedSEHK: 1875 | $350.57M | HK$3.56 | -4.30% |
| Surrozen, Inc.NasdaqCM: SRZN | $348.96M | $24.76 | -16.60% |
| Jiangsu Recbio Technology Co., Ltd.SEHK: 2179 | $347.01M | HK$4.42 | +0.23% |
| ROKIT Healthcare Inc.KOSDAQ: A376900 | $346.80M | ₩26,850.00 | -3.24% |
| Agenus Inc.NasdaqCM: AGEN | $334.50M | $7.43 | -3.13% |
| Indaptus Therapeutics, Inc.NasdaqCM: INDP | $334.44M | $2.44 | -2.79% |
Figures last refreshed Oct 11, 2026.